Redefining Regulatory Proof: The End of the Two‐Trial Paradigm
- DOI
- 10.1111/fcp.70110
- Published
- 2026-08-13
- Container
- Fundamental & Clinical Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/fcp.70110,
title = {Redefining Regulatory Proof: The End of the Two‐Trial Paradigm},
author = {Jean‐Christophe Lega and Steeve Provencher and Bruno Falissard and Clara Locher and Matthieu Roustit and Arthur Gougeon and Rémy Boussageon and Sylvie Chevret},
year = {2026},
journal = {Fundamental \& Clinical Pharmacology},
doi = {10.1111/fcp.70110},
url = {https://doi.org/10.1111/fcp.70110}
}RIS
TY - JOUR TI - Redefining Regulatory Proof: The End of the Two‐Trial Paradigm AU - Jean‐Christophe Lega AU - Steeve Provencher AU - Bruno Falissard AU - Clara Locher AU - Matthieu Roustit AU - Arthur Gougeon AU - Rémy Boussageon AU - Sylvie Chevret PY - 2026 JO - Fundamental & Clinical Pharmacology DO - 10.1111/fcp.70110 UR - https://doi.org/10.1111/fcp.70110 ER -
APA
Lega, J., Provencher, S., Falissard, B., Locher, C., Roustit, M., Gougeon, A., Boussageon, R., & Chevret, S. (2026). Redefining Regulatory Proof: The End of the Two‐Trial Paradigm. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70110
Source records
- crossref · retrieved 2026-09-25T16:29:57.014Z